Current orthopaedic implant surface technologies, including porous coatings and calcium phosphate overcoats, seek to promote bone cell ingrowth and mineral formation [1] [2] [3] [17, 18] . In contrast, we recently described a simple, one-step coating procedure that relies on the passive adsorption of a synthetic collagenbased peptide onto biomedical grade titanium (Ti) to enhance osseointegration [19] .
Introduction
Current orthopaedic implant surface technologies, including porous coatings and calcium phosphate overcoats, seek to promote bone cell ingrowth and mineral formation [1] [2] [3] . Although these approaches are successful in many cases, they can be restricted by slow rates of osseointegration and poor mechanical anchorage, especially in challenging clinical cases, such as those associated with large bone loss and poor bone quality [4] . In addition, these surface modification approaches rely on costly and manufacturing-intensive processes. As an alternative to these surface technologies, emerging biomimetic strategies have focused on the presentation of biological motifs, including extracellular matrix (ECM) sequences and growth factors [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] . The general paradigm of these bio-inspired approaches is the covalent immobilization (tethering) of the biological entities onto the underlying material support, which often involves multistep procedures to render the support suitable for biofunctionalization [17, 18] . In contrast, we recently described a simple, one-step coating procedure that relies on the passive adsorption of a synthetic collagenbased peptide onto biomedical grade titanium (Ti) to enhance osseointegration [19] . [20] [21] [22] [23] [24] . Osteoprogenitor cells and osteoblasts express a wide panel of integrins, including ␣5␤1, ␣v␤3, ␣3␤1, ␣8␤1 and ␣2␤1, which mediate interactions with collagens [25, 26] , fibronectin (FN) [27, 28] , laminins [29] and other matrix components [30, 31] . Specific integrin-ECM adhesive interactions regulate osteoblast function and mineralization [32] [33] [34] [35] [36] . Importantly, osteoblast integrin-ECM interactions are dynamic, and the extent of early and late mineralization is dependent on the particular integrin-matrix protein interactions engaged [27, [37] [38] [39] . [18] . The large majority of these efforts have centred on presenting short binding motifs incorporating the arginine-glycine-aspartic acid (RGD) minimal binding sequence from FN, bone sialoprotein and osteopontin [40] [41] [42] . Despite improved adhesion and differentiation in vitro, implant surfaces presenting RGD motifs do not consistently enhance osseointegration and bone formation in animal models [40, [43] [44] [45] 
Integrins are a large family of heterodimeric (␣␤) transmembrane receptors that mediate cell-matrix and cell-cell adhesion and trigger signals regulating cell survival, proliferation and differentiation

Because of the central roles of integrin-ECM interactions in osteoblast activities, integrins represent an attractive target in the design of biofunctionalized orthopaedic implants
Implantation procedure and functional analysis
Implantations into the tibiae of mature Sprague-Dawley male rats were conducted in accordance with an IACUC-approved protocol as described previously [19] . [52] , verified that both FNIII7-10 and pFN adsorbed in a bioactive orientation which is highly accessible to integrin binding (Fig. 1B) [53] .
Results
FN-mimetic ligand implant coatings
FN-mimetic ligand surfaces promote integrin-specific cell adhesion and signalling
To probe for the main integrin receptors actively engaged during adhesion, a centrifugation cell adhesion assay was performed in the presence and absence of integrin-specific blocking antibodies. rBMSCs displayed greater levels of adhesion to FNIII7-10-coated surfaces compared to Ti surfaces exposed to RGD or serum-treated Ti (P Ͻ 0.008), and adhesion levels were equivalent to pFNadsorbed surfaces (Fig. 2A) (Fig. 2B) . Taken together, these data establish that the FNIII7-10-adsorbed surfaces mainly support ␣5␤1-mediated adhesion, whereas the serum-treated and pFN surfaces engage ␣v-containing integrins, most likely ␣v␤3. 
To examine early integrin-mediated signalling on these supports, we analysed phosphorylation levels of important FAK tyrosines. FAK is an intracellular signalling molecule implicated in
Fig. 1 Surface density and accessibility of bioactive integrin ligands adsorbed on titanium surfaces. (A) Adsorbed surface densities of pFN and FNIII7-10 to Ti surfaces as measured by surface plasmon resonance. A total of at least eight independent measurements
Integrin-specific Ti coatings modulate in vitro osteogenic activities
We postulated that differences in integrin binding specificity and FAK activation modulate particular cell responses, including proliferation and expression of osteogenic markers. Indeed, a short-term (16 hrs) proliferation assay based on BrdU incorporation demonstrated that cells on FNIII7-10-treated Ti surfaces exhibited increased proliferation rates compared to pFN-coated (P Ͻ 0.05) or serum-treated Ti surfaces (P Ͻ 0.004) (Fig. 3C). In addition, cells displayed a significantly higher proliferation rate on pFNcoated surfaces over serum-treated Ti (P Ͻ 0.009). To examine if these integrin-specific adhesive and signalling cues influence osteoblastic differentiation, we used quantitative RT-PCR to monitor osteoblast-specific gene expression in 7-day rBMSC cultures.
Expression levels of Runx2/Cbfa1, a transcription factor involved in early osteoblastic differentiation [55] , were significantly elevated on FNIII7-10-treated surfaces compared to pFN (P Ͻ 0.006) or serum-treated Ti (P Ͻ 0.03) (Fig. 4A) (Fig. 5A and B (Fig. 5C) 
. In addition, RGD peptide-incubated Ti surfaces displayed no significant differences in calcium incorporation or von Kossa staining (data not shown) from serum-treated Ti surfaces; we attribute these results to the inadequate adsorption behaviour of the RGD peptide on Ti. Taken together, these results indicate that various biomolecular coatings of different integrin specificity elicit distinct osteoblastic responses in vitro.
Integrin ␣ 5 ␤ 1 -specific bioactive coatings enhance implant osseointegration
To evaluate the performance of these integrin-specific coatings in vivo, we quantified osseointegration of implants in a rat tibial cortical bone model using quantitative histomorphometry and pull-out mechanical testing (Fig. 6A and B) [19] . Extensive, adjoining bone matrix was visible in histological sections around FNIII7-10-treated Ti implants, whereas less substantial and more scattered areas of mineral were present around the pFN treated and, especially, the uncoated Ti implants (Fig. 6C) [56] . Pull-out mechanical testing (N ϭ 7-9 implants per surface condition) revealed significantly higher mechanical fixation of the FNIII7-10-treated implants over both pFN-treated (85%, P Ͻ 0.05) and unmodified Ti (290%, P Ͻ 0.001), the current clinical standard (Fig. 6E) . Notably, implants coated with pFN also displayed higher fixation than the unmodified Fig. 4 FNIII7-10-treated 
